Dolby Laboratories, Inc. reported $1.26B of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.26B (to Q3 2022). Net income: $226M, trailing twelve months to Q3 2026. Free cash flow: $393M, trailing twelve months to Q3 2026. EPS: $2.35, trailing twelve months to Q3 2026.

DLBDolby Laboratories, Inc.

Industrials

$58.76-16% 1Y

$58.76

$48.5152 weeks$71.44

DLB as reported

Dolby Laboratories, Inc. reported $1.26B of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed.

$1.26B

Revenue, trailing twelve months · to Q3 2022 · every figure below is as filed, with no scoring applied

Net income: $226M
Net income · −14% year on year · trailing twelve months to Q3 2026
Free cash flow: $393M
Free cash flow · −10% year on year · trailing twelve months to Q3 2026
EPS: $2.35
EPS · −14% year on year · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for DLB, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.26B	n/a	Q3 2022 · 16 quarters behind
Net income	$226M	−14%	Q3 2026
EPS	$2.35	−14%	Q3 2026
Gross margin	89%	n/a	Q3 2022 · 16 quarters behind
Operating margin	17%	n/a	Q3 2022 · 16 quarters behind
Net margin	16%	n/a	Q3 2022 · 16 quarters behind
ROE	9.3%	n/a	Q3 2026
ROA	7.5%	n/a	Q3 2026
Free cash flow	$393M	−10%	Q3 2026
P/E	25.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.